Which clinical finding is characteristic of Kawasaki disease?

Which clinical finding is characteristic of Kawasaki disease?

• A. Bilateral Conjunctival Injections
• B. Hemoptysis
• C. Jaundice
• D. Hypotension

Answer: (A)

Bilateral conjunctival injection is a hallmark feature of Kawasaki disease because the illness drives a systemic vasculitis that commonly affects the eyes early on, causing bright red, nonexudative redness in both conjunctiva. This ocular sign is one of the classic mucocutaneous findings used to identify Kawasaki disease in a febrile child, alongside changes of the mucous membranes, extremities, a polymorphous rash, and cervical lymphadenopathy. The other options don’t fit the typical Kawasaki presentation. Hemoptysis points to a pulmonary issue rather than a characteristic sign of this vasculitis. Jaundice suggests liver or biliary disease, not a defining feature of Kawasaki. Hypotension can occur with shock or other conditions but isn’t a key diagnostic sign of Kawasaki disease itself. Recognizing the bilateral, nonexudative conjunctival injection helps distinguish Kawasaki disease from other febrile illnesses and drives timely treatment to reduce coronary artery complications.

Bilateral conjunctival injection is a hallmark feature of Kawasaki disease because the illness drives a systemic vasculitis that commonly affects the eyes early on, causing bright red, nonexudative redness in both conjunctiva. This ocular sign is one of the classic mucocutaneous findings used to identify Kawasaki disease in a febrile child, alongside changes of the mucous membranes, extremities, a polymorphous rash, and cervical lymphadenopathy.

The other options don’t fit the typical Kawasaki presentation. Hemoptysis points to a pulmonary issue rather than a characteristic sign of this vasculitis. Jaundice suggests liver or biliary disease, not a defining feature of Kawasaki. Hypotension can occur with shock or other conditions but isn’t a key diagnostic sign of Kawasaki disease itself. Recognizing the bilateral, nonexudative conjunctival injection helps distinguish Kawasaki disease from other febrile illnesses and drives timely treatment to reduce coronary artery complications.